Vivimed Labs Limited Files SEBI Compliance Certificate for Q4 FY26
Vivimed Labs Limited received a certificate from its RTA, Aarthi Consultants Private Limited, confirming compliance with SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The RTA processed dematerialization requests within the stipulated 15-day period.
This is a standard regulatory filing that is expected from listed companies on a quarterly basis. It does not introduce any new material information that would significantly affect the company's operations or market valuation.
The announcement is a routine compliance filing and does not contain any new financial information or strategic developments that would impact the company's stock positively or negatively.
Vivimed Labs Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended March 31, 2026. The certificate was received from the company's Registrar and Share Transfer Agent (RTA), Aarthi Consultants Private Limited. The RTA confirmed that during the period from January 1, 2026, to March 31, 2026, all securities received for dematerialization were processed within 15 days. This involved the dematerialization of securities, listing them on the stock exchange, and cancelling the original physical certificates, with the depository being substituted as the registered owner.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.